This document discusses stem cell research and cloning. It begins with the history of stem cell research and defines different types of stem cells. It then discusses where stem cells come from and the potential benefits of stem cell research. The document also provides an overview of cloning, including important milestones in cloning research. It notes some issues related to stem cell research and cloning, such as religious, medical, and ethical concerns. In conclusion, it states that stem cells may provide future treatment options, and while cloning technology has advanced, it remains controversial.
A stem cell is a "blank" cell that can give rise to multiple tissue types such as a skin, muscle, or nerve cell.
Under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions.
iPSCs are pluripotent; unlike ESC, iPSCs are not derived from the embryo, but instead created from differentiated cells in the lab through a process – cellular reprogramming.
Cellular coning refers to generation of genetically identical cells from parent cells. This presentation teaches differences between cell coning and molecular cloning and various methods of cell cloning. Sample questions are also provided for your review of concept learned
A stem cell is a "blank" cell that can give rise to multiple tissue types such as a skin, muscle, or nerve cell.
Under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions.
iPSCs are pluripotent; unlike ESC, iPSCs are not derived from the embryo, but instead created from differentiated cells in the lab through a process – cellular reprogramming.
Cellular coning refers to generation of genetically identical cells from parent cells. This presentation teaches differences between cell coning and molecular cloning and various methods of cell cloning. Sample questions are also provided for your review of concept learned
What is Stem Cell ?
History of Stem Cells ?
Stages of Embryogenesis
Blastocyst Diagram
Three types of stem cells
Differentiation of ESC
Adult Stem Cells
Bone Marrow
Umbilical cord stem cells
Factors known to affect stem cells
Niche cells activates Stem cells
Regenerative Medicine : Indian Scenario
Genetic Discrimination by Thalia EscobedoThaliae96
This powerpoint was part of the oral/visual component of the Advocacy Proposal, which was an important component, as it allowed me to talk about the social of genetic discrimination to my peers and propose my solution: The California Genetic Nondiscrimination Act of 2011.
Introduction
History
Cell culture techniques
Species cloned
Approaches of cell cloning
Monolayer culture- Dilution cloning
Microtitration plate
Suspension culture- Cloning in agar
Cloning in methocel
Isolation of clone
By clonal rings
By suspension clone
Application of cell cloning
Conclusion
Reference
Introduction
History
Scale up in suspension:Stirred culture,Continuous flow culture,Air- lift culture,Nasa bioreactor
Scale up in monolayer culture: Roller bottle culture , multisurface culture,fixed -bed culture
Other type of culture for scaling up: HARV Vessels,STLV vessels
Monitoring of scale up
Conclusion
References
What is Stem Cell ?
History of Stem Cells ?
Stages of Embryogenesis
Blastocyst Diagram
Three types of stem cells
Differentiation of ESC
Adult Stem Cells
Bone Marrow
Umbilical cord stem cells
Factors known to affect stem cells
Niche cells activates Stem cells
Regenerative Medicine : Indian Scenario
Genetic Discrimination by Thalia EscobedoThaliae96
This powerpoint was part of the oral/visual component of the Advocacy Proposal, which was an important component, as it allowed me to talk about the social of genetic discrimination to my peers and propose my solution: The California Genetic Nondiscrimination Act of 2011.
Introduction
History
Cell culture techniques
Species cloned
Approaches of cell cloning
Monolayer culture- Dilution cloning
Microtitration plate
Suspension culture- Cloning in agar
Cloning in methocel
Isolation of clone
By clonal rings
By suspension clone
Application of cell cloning
Conclusion
Reference
Introduction
History
Scale up in suspension:Stirred culture,Continuous flow culture,Air- lift culture,Nasa bioreactor
Scale up in monolayer culture: Roller bottle culture , multisurface culture,fixed -bed culture
Other type of culture for scaling up: HARV Vessels,STLV vessels
Monitoring of scale up
Conclusion
References
Orthobiologics - PRP, BMC the real story so far!Vaibhav Bagaria
A basic presentation on the role of orthobiologics, PRP, Bone marrow aspirate concentrate in orthopaedics. Insights, and future research directions in a rapidly evolving field.
This presentation contains various details from history of cloning to what one should expect in the future from cloning and also different cloning methods
The complete, compiled presentation on stem cell research. The contents include background history along with the introduction, different stem cell types, cultivation process, stem cell cloning and potential uses, the negative aspects and ethical concerns regarding stem cell therapy. Different examples of the useful work in stem cell therapy field has also been mentioned.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
Richard's aventures in two entangled wonderlandsRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
4. TYPES OF STEM CELLS
4
Type of stem cell What it can be Examples
Totipotent cells Each cell can
develop into a
new individual
Cells of embryo
of 1-3 days
Pluripotent cells Each cell can
form any cell type
(over 200)
Cells of blastocyst
5-14 days
Multipotent cells Cells differentiate
and can form a
number of tissue
types.
Fetal tissue, cord
blood, adult cells
5. WHERE DO THEY COME FROM ??
• Embryos: Embryonic stem (ES) cells are stem cells derived
from the inner cell mass of a blastocyst, an early-stage embryo.
• Adults: Adult stem cells, also called somatic stem cells, are
stem cells which maintain and repair the tissue in which they
are found.
• Umbilical cord: Blood cells from the post-delivery umbilical
cord contain undifferentiated cells.
5
8. CLONING
• Cloning in general refer to as reproduction without mating.
• Cloning is a scientific process that allows scientists to copy the
genetic traits of a plant or animal to create one or more living
replicas.
• The baby that develops will have the identical genetic traits as
the animal that provided the nucleus used to fertilize the host’s
egg. 8
9. MILESTONES IN HISTORY OF
CLONING
• In 1996 - Ian Wilmut and Keith Campbell cloned the first animal from adult
cells. Dolly the sheep, born on July 5, 1996, was created using the so-called
Roslin Technique.
• In 1997, Infigen Inc., a biotechnology company, created the first cloned calf
named Gene in the world. It was cloned from a non-embryonic cell.
• In 1998 - Ryuzo Yanagimachi, Toni Perry and Teruhiko Wakayama of the
University of Hawaii reported cloning fifty mice from adult mouse cells.
• In 2001 - Scientists at Advanced Cell Technology, Inc. announced the birth of a
cloned baby bull gaur (a large wild ox) named Noah. Noah was the first
endangered animal to be cloned.
9
13. TYPES OF CLONING
• Therapeutic cloning : It involves the use
of (stem) cells for medicinal or research
purposes.
• Reproductive cloning: It involve the use
(stem) cells to create cloned humans or animals.
13
14. WHY CLONING ??
14
• Substitute for Natural Reproduction
• Obtain Specific Traits in Organisms
• Cloning animals for excellent traits
• Possibility of repopulating
the endangered species
19. CURRENT LAWS
19
• In 2001 Bush announced federal funds can only be used to
study embryonic cells that already exist, all other will be
done by using private funding.
• United Kingdom made it legal to clone human embryos for
medical research.
• South Korea, Sweden & Singapore allow therapeutic
cloning.
• Australia did banned cloning in 2006 but now therapeutic
cloning is legal
20. FUTURE ASPECT & CONCLUSION
20
• Stem cells pose a bright future for the therapeutic world by promising treatment
options for the diseases which are considered as non-curable now a days.
• Although there has been limited success in cloning some animals, it's still seen as a
viable technology.
• Ever since the announcement of the birth of Dolly, additional
sheep, cows, goats, pigs, and mice have been cloned.
• Cloning is a big first step. Genetic
manipulation of cloned animals is the
future direction of the cloning frontier.